MIAT and head and neck squamous cell carcinoma: In this study, we used TCGA-HNSCC datasets and clinical samples to verify the high expression of MIAT in HNSCC tissues, but the high expression of MIAT was beneficial to the prognosis of patients, which may be a compensatory increase in tumor to increase the infiltration of tumor immune cells and improve the anti-tumor immunity of HNSCC patients.